Literature DB >> 25449696

Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.

Chengcheng Zou1, Juan Chen1, Ke Chen1, Sen Wang1, Yiyi Cao1, Jinnan Zhang1, Yanrui Sheng1, Ailong Huang1, Hua Tang2.   

Abstract

The hepatitis B virus (HBV) is responsible for most of hepatocellular carcinoma (HCC). However, whether HBV plays an important role during hepatocarcinogenesis through effecting miRNAs remains unknown. Here, we reported that HBV up-regulated microRNA-181a (miR-181a) by enhancing its promoter activity. Simultaneously, we found that miR-181a inhibited apoptosis in vitro and promoted tumor cell growth in vivo. TNF receptor superfamily member 6 (Fas) was further identified as a target of miR-181a. We also found that Fas could reverse the apoptosis-inhibition effect induced by miR-181a. Moreover, HBV could inhibit cell apoptosis by down-regulating Fas expression, which could be reversed by miR-181a inhibitor. Our data demonstrated that HBV suppressed apoptosis of hepatoma cells by up-regulating miR-181a expression and down-regulating Fas expression, which may provide a new understanding of the mechanism in HBV-related HCC pathogenesis.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Fas; HBV; HCC; miR-181a

Mesh:

Substances:

Year:  2014        PMID: 25449696     DOI: 10.1016/j.yexcr.2014.11.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  11 in total

Review 1.  Apoptosis in liver carcinogenesis and chemotherapy.

Authors:  Joaquim Moreno-Càceres; Isabel Fabregat
Journal:  Hepat Oncol       Date:  2015-11-11

2.  Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.

Authors:  Shuming He; Shumei Zeng; Zhi-Wei Zhou; Zhi-Xu He; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-02-18       Impact factor: 4.162

3.  Upregulation of PP2Ac predicts poor prognosis and contributes to aggressiveness in hepatocellular carcinoma.

Authors:  Shao-Juan Gong; Xiao-Jun Feng; Wei-Hua Song; Jian-Ming Chen; Shou-Mei Wang; Dong-Juan Xing; Ming-Hua Zhu; Shu-Hui Zhang; Ai-Min Xu
Journal:  Cancer Biol Ther       Date:  2015-11-30       Impact factor: 4.742

Review 4.  MicroRNAs as Important Players in Host-hepatitis B Virus Interactions.

Authors:  Bouchra Kitab; Hanane Salih Alj; Sayeh Ezzikouri; Soumaya Benjelloun
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

5.  Role of microRNAs in inflammation-associated liver cancer.

Authors:  Lin Huan; Lin-Hui Liang; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

6.  Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.

Authors:  Shuzhen Chang; Binhe Chen; Xiaoyan Wang; Keqin Wu; Yuqiu Sun
Journal:  BMC Cancer       Date:  2017-04-07       Impact factor: 4.430

7.  Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma.

Authors:  Yiming Luo; Furong Liu; Shenqi Han; Yongqiang Qi; Xinsheng Hu; Chenyang Zhou; Huifang Liang; Zhiwei Zhang
Journal:  Front Mol Biosci       Date:  2021-05-20

8.  Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Authors:  Yiyi Cao; Juan Chen; Dan Wang; Hong Peng; Xixi Tan; Dongmei Xiong; Ailong Huang; Hua Tang
Journal:  Oncotarget       Date:  2015-11-10

Review 9.  The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways.

Authors:  Kurt Sartorius; Leo Swadling; Ping An; Julia Makarova; Cheryl Winkler; Anil Chuturgoon; Anna Kramvis
Journal:  Viruses       Date:  2020-07-10       Impact factor: 5.818

10.  Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma.

Authors:  Shui Liu; Xiaoxiao Yao; Dan Zhang; Jiyao Sheng; Xin Wen; Qingyu Wang; Gaoyang Chen; Zhaoyan Li; Zhenwu Du; Xuewen Zhang
Journal:  Biomed Res Int       Date:  2018-08-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.